Laxmi Dental Ltd

AI
Laxmi Dental Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Laxmi Dental Ltd

₹ 196 -0.05%
06 Nov - close price
laxmidentallimited.com BSE: 544339 NSE: LAXMIDENTL
About

Incorporated in 2004, Laxmi Dental is an integrated dental products company offering a comprehensive portfolio of Dental Products[1]

Key Points

Leading Dental Company[1]
Laxmi Dental is India’s only end-to-end integrated dental products company, operating across the full dental value chain — dental laboratory services, clear aligners, aligner materials & machines, and paediatric dental products. It is the second-largest domestic dental lab player and the largest Indian export dental laboratory

Website BSE NSE
  • Market Cap ₹ 1,081 Cr.
  • Current Price ₹ 196
  • High / Low ₹ 345 / 156
  • Stock P/E 29.8
  • Book Value ₹ 48.1
  • Dividend Yield 0.00 %
  • ROCE 15.0 %
  • ROE 14.8 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has delivered good profit growth of 103% CAGR over last 5 years

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Tax rate seems low
  • Working capital days have increased from 72.9 days to 182 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies

Part of BSE Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
48 55 60 57 62 61 66 72 66 74 75 80
44 43 46 48 52 51 54 61 59 60 60 64
Operating Profit 4 12 14 9 10 10 12 11 7 14 14 15
OPM % 8% 21% 23% 15% 16% 16% 18% 15% 11% 18% 19% 19%
-0 -0 6 1 1 2 2 2 -4 2 2 2
Interest 1 1 1 1 2 1 0 0 0 0 0 0
Depreciation 3 3 3 3 4 4 4 4 4 4 4 5
Profit before tax -1 7 16 5 5 6 10 9 -1 11 12 12
Tax % -140% 16% 11% 23% 23% 41% 24% 20% -175% 4% 21% 19%
2 8 17 6 5 4 8 9 2 10 10 10
EPS in Rs 0.84 2.78 6.04 2.12 0.93 0.78 1.53 1.55 0.36 1.83 1.87 1.82
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
150 92 137 162 194 239 278 294
146 88 130 152 169 196 234 244
Operating Profit 3 4 7 9 24 43 44 50
OPM % 2.3% 4.6% 4.8% 6% 13% 18% 16% 17%
2 0 -10 2 0 10 3 3
Interest 3 3 4 4 6 6 2 1
Depreciation 7 6 8 11 12 15 16 18
Profit before tax -4 -4 -16 -5 7 31 29 34
Tax % 5% 8% 15% 4% -136% 21% 9%
-5 -5 -19 -4 25 32 29 32
EPS in Rs -1.77 -1.78 -6.80 -1.47 9.18 5.78 5.27 5.88
Dividend Payout % 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 25%
3 Years: 20%
TTM: 13%
Compounded Profit Growth
10 Years: %
5 Years: 103%
3 Years: 124%
TTM: 41%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -37%
Return on Equity
10 Years: %
5 Years: 18%
3 Years: 22%
Last Year: 15%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Equity Capital 0.31 0.31 0.31 0.31 0.31 11 11 11
Reserves 37 33 9 6 31 198 232 254
37 39 50 50 61 20 13 15
31 34 43 40 46 60 40 36
Total Liabilities 106 106 103 97 139 288 297 316
39 42 40 40 46 51 63 74
CWIP 0 7 0 0 0 0 0 0
Investments 0 0 0 0 6 10 27 35
66 56 63 56 87 227 207 207
Total Assets 106 106 103 97 139 288 297 316

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
12 10 -2 14 8 44 -5
-18 -9 3 -10 -11 -29 -78
6 -0 -4 -1 -3 111 -18
Net Cash Flow 0 0 -3 3 -5 125 -101
Free Cash Flow -5 0 -0 5 -5 28 -23
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 357% 226% -30% 157% 38% 109% 4%

Ratios

Consolidated / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 64 64 54 46 47 56 60
Inventory Days 186 305 272 212 397 156
Days Payable 197 273 245 197 585 68
Cash Conversion Cycle 54 96 81 61 47 -132 147
Working Capital Days 13 3 -3 -13 0 37 182
ROCE % 3% -1% 1% 18% 19% 15%

Insights

In beta
Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Aligner Cases Sold (Bizdent)
cases

Log in to view insights

Please log in to see hidden values.

Login
Digital Units Penetration - Domestic Lab
% of domestic lab units
Digital Units Penetration - International Lab
% of international lab units
Domestic Lab Metal-Free Revenue Share
% of domestic lab revenue
Domestic Lab Units Sold
units
International Lab Units Sold
units
Paediatric Crowns Units Sold (Kids-e-Dental)
units ・Standalone data
Intraoral Scanner Units Sold
scanners

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
41.70% 41.70% 41.70% 41.70% 41.77% 41.80% 41.75%
34.24% 33.59% 32.39% 32.45% 31.20% 30.10% 6.57%
12.86% 14.30% 11.85% 10.82% 10.52% 10.89% 10.68%
11.19% 10.39% 14.05% 15.01% 16.50% 17.21% 41.00%
No. of Shareholders 29,48227,95737,90938,63538,16136,93736,680

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls